NTRK1 and Alzheimer disease: As we have previously shown [13], an additional low-molecular weight (LMW) phospho-Trk –immunoreactive protein (about 105 kDa) is robustly phosphorylated in the rodent brain after single or repeated AD treatment (Figure 2A).